Article successfully added.

CyFlow™ CD84 FITC

CyFlow™ CD84 FITC
Alternative Name: SLAMF5
Antibody: Yes
Antigen: CD84
Application: Flow cytometry
Clonality: monoclonal
Clone: CD84.1.21
Emission Maximum: 518 nm
Excitation Maximum: 490 to 495 nm
Field of Interest: Immunophenotyping
Format/Fluorochrome: FITC
Isotype: IgG2a
Laser: Blue
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: AX231373

For Research Use Only

$235.00 USD*

Price excludes any applicable taxes plus shipping costs

Quantity 100 tests Volume 0.4 mL Immunogen CD84-transfected 300.19 cell line... more
CyFlow™ CD84 FITC
Quantity100 tests
Volume0.4 mL
ImmunogenCD84-transfected 300.19 cell line
Background InformationCD84 is a highly glycosylated homophilic receptor of SLAM family. It is expressed on platelets and various types of leukocytes, especially following their activation. Ligation of CD84 leads to its phosphorylation on tyrosine residues within the cytoplasmic tail. These docking sites are recognized by downstream signaling molecules, such as phosphatase SHP-2 and adaptor protein SAP/SH2D1A. The function of CD84 has not been fully elucidated yet. Although predominantly activating receptor, its modulating activity was also demonstrated.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 4·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Sayós J, Martín M, Chen A, Simarro M, Howie D, Morra M, Engel P, Terhorst C: Cell surface receptors Ly‑9 and CD84 recruit the X‑linked lymphoproliferative disease gene product SAP. Blood. 2001 Jun 15; 97(12):3867‑74. < PMID: 11389028 > | Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C: Characterization of SH2D1A missense mutations identified in X‑linked lymphoproliferative disease patients. J Biol Chem. 2001 Sep 28; 276(39):36809‑16. < PMID: 11477068 > | Martin M, Romero X, de la Fuente MA, Tovar V, Zapater N, Esplugues E, Pizcueta P, Bosch J, Engel P: CD84 functions as a homophilic adhesion molecule and enhances IFN‑gamma secretion: adhesion is mediated by Ig‑like domain 1. J Immunol. 2001 Oct 1; 167(7):3668‑76. < PMID: 11564780 > | Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D, Rietdijk S, Thompson A, Coyle AJ, Denny C, Yaffe MB, Engel P, Eck MJ, Terhorst C: Structural basis for the interaction of the free SH2 domain EAT‑2 with SLAM receptors in hematopoietic cells. EMBO J. 2001 Nov 1; 20(21):5840‑52. < PMID: 11689425 > | Romero X, Zapater N, Calvo M, Kalko SG, de la Fuente MA, Tovar V, Ockeloen C, Pizcueta P, Engel P: CD229 (Ly{09} lymphocyte cell surface receptor interacts homophilically through its N‑terminal domain and relocalizes to the immunological synapse. J Immunol. 2005 Jun 1; 174(11):7033‑42. < PMID: 15905546 >